Warning: This security is no longer trading.
Menlo Therapeutics Inc. has acquired Foamix Pharmaceuticals
Foamix Pharmaceuticals Ltd. - Ordinary Shares (FOMX): Price and Financial Metrics
FOMX Price/Volume Stats
| Current price | $2.99 | 52-week high | $4.84 |
| Prev. close | $3.24 | 52-week low | $1.97 |
| Day low | $2.90 | Volume | 1,930,800 |
| Day high | $3.44 | Avg. volume | 596,231 |
| 50-day MA | $3.94 | Dividend yield | N/A |
| 200-day MA | $3.16 | Market Cap | 184.13M |
FOMX Stock Price Chart Interactive Chart >
Foamix Pharmaceuticals Ltd. - Ordinary Shares (FOMX) Company Bio
Foamix Pharmaceuticals is a clinical-stage specialty pharmaceutical company focused on developing and commercializing its proprietary minocycline foam for the treatment of acne and other skin conditions. The company was founded in 2003 and is based in Rehovot, Israel.
FOMX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 0.00% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -7.24% |
Continue Researching FOMX
Want to do more research on Foamix Pharmaceuticals Ltd's stock and its price? Try the links below:Foamix Pharmaceuticals Ltd (FOMX) Stock Price | Nasdaq
Foamix Pharmaceuticals Ltd (FOMX) Stock Quote, History and News - Yahoo Finance
Foamix Pharmaceuticals Ltd (FOMX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...